Infant Malaria Vaccine Schedule Optimization

NCT06879327 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

964

Enrollment

OTHER

Sponsor class

Conditions

Malaria Vaccines

Interventions

BIOLOGICAL: R21 Matrix-M (R21/MM) Malaria Vaccine
BIOLOGICAL: Placebo
BIOLOGICAL: Hexavalent Vaccine
BIOLOGICAL: Pneumococcal Polysaccharide Conjugate Vaccine
BIOLOGICAL: Rotavirus, Live Attenuated (Oral) Vaccine
BIOLOGICAL: Measles and Rubella Vaccine
BIOLOGICAL: Meningococcal (A, C, Y, W, X) polysaccharide conjugate vaccine
BIOLOGICAL: Yellow Fever vaccine
BIOLOGICAL: Typhoid Conjugate vaccine

Sponsor

PATH

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]